Adipocytokines and Insulin Resistance The possible role of lipocalin-2, retinol binding protein-4, and adiponectin

被引：139

作者：

Esteve, Eduardo ^{[1
]}

Ricart, Wifredo

Manuel Fernandez-Real, Jose

机构：

[1] Biomed Res Inst Girona, Unit Diabet Endocrinol & Nutr, Girona, Spain

来源：

DIABETES CARE | 2009年 / 32卷

关键词：

CORONARY-HEART-DISEASE; SERUM RETINOL-BINDING-PROTEIN-4; NONOBESE SUBJECTS; OBESITY; FAT; IDENTIFICATION; SENSITIVITY; EXPRESSION; ADOLESCENT; RECEPTORS;

D O I：

10.2337/dc09-S340

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S362 / S367

页数：6

共 38 条

[1] Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects [J].

Broch, Montserrat ;

Vendrell, Joan ;

Ricart, Wifredo ;

Richart, Cristobal ;

Fernandez-Real, Jose-Manuel .

DIABETES CARE, 2007, 30 (07) :1802-1806

[2] Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain [J].

Cavusoglu, Erdal ;

Ruwende, Cyril ;

Chopra, Vineet ;

Yanamadala, Sunitha ;

Eng, Calvin ;

Clark, Luther T. ;

Pinsky, David J. ;

Marmur, Jonathan D. .

EUROPEAN HEART JOURNAL, 2006, 27 (19) :2300-2309

[3] Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes [J].

Cho, Young Min ;

Youn, Byung-Soo ;

Lee, Hyewon ;

Lee, Namseok ;

Min, Sung-Shik ;

Kwak, Soo Heon ;

Lee, Hong Kyu ;

Park, Kyong Soo .

DIABETES CARE, 2006, 29 (11) :2457-2461

[4] Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease [J].

Choi, K. M. ;

Lee, J. S. ;

Kim, E. J. ;

Baik, S. H. ;

Seo, H. S. ;

Choi, D. S. ;

Oh, D. J. ;

Park, C. G. .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (02) :203-207

[5] Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits [J].

Craig, Rebekah L. ;

Chu, Winston S. ;

Elbein, Steven C. .

MOLECULAR GENETICS AND METABOLISM, 2007, 90 (03) :338-344

[6] Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia [J].

Despres, JP ;

Golay, A ;

Sjostrom, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2121-2134

[7] Adiponectin and the development of type 2 diabetes - The atherosclerosis risk in communities study [J].

Duncan, BB ;

Schmidt, MI ;

Pankow, JS ;

Bang, HJ ;

Couper, D ;

Ballantyne, CM ;

Hoogeveen, RC ;

Heiss, G .

DIABETES, 2004, 53 (09) :2473-2478

[8] Insulin resistance and chronic cardiovascular inflammatory syndrome [J].

Fernández-Real, JM ;

Ricart, W .

ENDOCRINE REVIEWS, 2003, 24 (03) :278-301

[9] Innate immunity, insulin resistance and type 2 diabetes [J].

Fernandez-Real, Jose Manuel ;

Pickup, John C. .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2008, 19 (01) :10-16

[10] Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron [J].

Flo, TH ;

Smith, KD ;

Sato, S ;

Rodriguez, DJ ;

Holmes, MA ;

Strong, RK ;

Akira, S ;

Aderem, A .

NATURE, 2004, 432 (7019) :917-921

← 1 2 3 4 →